NASDAQ:MLNT - Nasdaq -
MJCO – MJCO leads the way today as the best performing small cap stock, closing up 72.25%.
VRNA – VRNA leads the way today as the best performing small cap stock, closing up 115.64%.
AHT – AHT leads the way today as the best performing small cap stock, closing up 813.11%.
GENE – GENE leads the way today as the best performing small cap stock, closing up 143.81%.
PRCP – PRCP leads the way today as the best performing small cap stock, closing up 111.73%.
JAKK – JAKK leads the way today as the best performing small cap stock, closing up 819.61%.
BGFV – BGFV leads the way today as the best performing small cap stock, closing up 39.58%.
JRJC – JRJC leads the way today as the best performing small cap stock, closing up 40.69%.
CRVS – CRVS leads the way today as the best performing small cap stock, closing up 80.66%.
ROSE – ROSE leads the way today as the best performing small cap stock, closing up 57.58%.
GNUS – GNUS leads the way today as the best performing small cap stock, closing up 53.68%.
GNUS – GNUS leads the way today as the best performing small cap stock, closing up 53.68%.
SHIP – SHIP leads the way today as the best performing small cap stock, closing up 1,257.87%.
PDSB – PDSB leads the way today as the best performing small cap stock, closing up 60.49%.
EKSO – EKSO leads the way today as the best performing small cap stock, closing up 135.16%.
LLEX – LLEX leads the way today as the best performing small cap stock, closing up 63.91%.
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ:TTPH) is not over yet. La Jolla Pharmaceuticals (NASDAQ:LJPC) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0
MCEP – MCEP leads the way today as the best performing small cap stock, closing up 94.06%.
XELA – XELA leads the way today as the best performing small cap stock, closing up 87.95%.
EFOI – EFOI leads the way today as the best performing small cap stock, closing up 411.02%.
Emerging victorious in a bidding joust with AcelRx Pharmaceuticals (NASDAQ:ACRX), Melinta Therapeutics (NASDAQ:MLNT) enters into a definitive merger agreement with Tetraphase Pharmaceuticals (NASDAQ:T
XOG – XOG leads the way today as the best performing small cap stock, closing up 247.91%.
VAL – VAL leads the way today as the best performing small cap stock, closing up 133.62%.
LUB – LUB leads the way today as the best performing small cap stock, closing up 121.07%.
AcelRx Pharmaceuticals (NASDAQ:ACRX) announces that it does not intend to revise its latest cash-and-stock bid for Tetraphase Pharmaceuticals (NASDAQ:TTPH) and expects the termination of their previou
ENT – ENT leads the way today as the best performing small cap stock, closing up 74.31%.
Undeterred by a revised bid from AcelRx Pharmaceuticals (NASDAQ:ACRX), Melinta Therapeutics (NASDAQ:MLNT) has sweetened its offer for Tetraphase Pharmaceuticals (NASDAQ:TTPH) to $34M in cash plus $16.
HTZ – HTZ leads the way today as the best performing small cap stock, closing up 133.93%.
Signaling its determination to close the deal amid rival offers, AcelRx Pharmaceuticals (ACRX -4.0%) has increased its bid for Tetraphase Pharmaceuticals (TTPH -8.3%) to $30M in cash and stock plus an
MTC – MTC leads the way today as the best performing small cap stock, closing up 86.36%.
SPHS – SPHS leads the way today as the best performing small cap stock, closing up 131.58%.
SPHS – SPHS leads the way today as the best performing small cap stock, closing up 131.58%.
The board of Tetraphase Pharmaceuticals (NASDAQ:TTPH) has determined that the recent acquisition offer of up to $39.5M in upfront cash and a potential CVR payout from Melinta Therapeutics (NASDAQ:MLNT
XTNT – XTNT leads the way today as the best performing small cap stock, closing up 160.28%.
RENN – RENN leads the way today as the best performing small cap stock, closing up 81.40%.
OMP – OMP leads the way today as the best performing small cap stock, closing up 79.31%.
SRNE – SRNE leads the way today as the best performing small cap stock, closing up 158.02%.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) discloses that it received an unsolicited bid yesterday from Melinta Therapeutics (NASDAQ:MLNT) for $27.0M in cash plus an additional $12.5M payable under a co